Michael Weisman

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

Philip J. Clements, Peter A. Lachenbruch, Jill Siebold et al. · PubMed · 1995 · 877 citations

Medicine, Dermatology, Dermatopathology +9

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

Carol A. Langford, David Cuthbertson, Steven R. Ytterberg et al. · Arthritis & Rheumatology · 2017 · 392 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Recombinant Human Relaxin in the Treatment of Scleroderma

James R. Seibold, Joseph H. Korn, Robert W. Simms et al. · Annals of Internal Medicine · 2000 · 266 citations

Medicine, Dermatology, Pharmacotherapy +6

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis

Carol A. Langford, David Cuthbertson, Steven R. Ytterberg et al. · Arthritis & Rheumatology · 2017 · 165 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double‐blind, placebo‐controlled trial

Dinesh Khanna, Philip J. Clements, Daniel E. Fürst et al. · Arthritis & Rheumatism · 2009 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8